Farm Animal Drugs Market will reach a value of US$ 29.4 Bn by 2032 at a CAGR of 5.5% | Future Market Insights

Farm Animal Drugs Market Outlook (2022-2032)

[250 Pages Report] The global farm animal drugs market size is expected to reach a valuation of US$ 17.2 Bn by the end of 2022, and further expand at a CAGR of 5.5% from 2022 to 2032. The market is projected to reach a valuation of ~US$ 29.4 Bn by the end of 2032. Livestock animals are leading the market in terms of animals and the segment held a share of about 92.4% in 2021.

Omnivorous people are directly dependent on healthy, productive animals for their food supply and financial security, especially in low- and middle-income nations, where a high percentage of people make a living by raising animals. The Health for Animals Organization estimates that 1.3 billion individuals keep livestock worldwide (2021). As a result, controlling and preventing animal diseases is essential to achieving the sustainable development goals and is a worldwide public benefit.

Request Sample:
https://www.futuremarketinsights.com/reports/sample/rep-gb-2402

In addition, antibiotics are frequently used to treat sick animals. Failure to follow drug withdrawal periods in farm animals leads to the production of contaminated products and raises concerns about their safety when consumed by humans. Over certain maximum levels of antibiotic residue, items are regarded unfit for ingestion and should be thrown away in a manner that minimizes the risk of environmental contamination.

Humans can contract antimicrobial-resistant bacteria from food animals either directly or indirectly through contaminated environments, compromised foods, or direct contact with animals. These factors are projected to compel pharmaceutical companies to develop innovative farm animal drugs.

2012-2021 Global Farm Animal Drugs Demand Outlook Compared to 2022-2032 Forecast

The market for farm animal drugs held approximately 54.9% of the global veterinary medicine market, which was worth ~US$ 29.4 Bn in 2021. Sales of farm animal drugs expanded at a CAGR of 5.8% from 2012 to 2021 owing to rising advancements in the field of zoonotic disease diagnostics.

Cross-sectoral cooperation is prioritized in order to control risks and effects from the interface between people, animals, and the environment to enhance global health security. A key element in reaching this goal is making sure that veterinary medications are of high quality. Veterinary medicinal items that are substandard and falsified (SF) will logically have a negative impact on food security, farming & animal trading networks, and agricultural production.

Limited active pharmaceutical ingredient (API) concentrations in SF antibiotics or low bioavailability, as seen by poor dissolving, increase the risk of sub therapeutic plasma levels. Antimicrobial resistance (AMR), which can be transmitted to people through contact with animals, food, or their environment, may be selected for by pathogens that "see" suboptimal drug levels in animals.

Top Trend Pushing Sales of Farm Animal Drugs

Emergence of Controlled Release Technology
Controlled-release (CR) technology has a lot of potential in the veterinary sector. The welfare of animals (reduced strain from restrictions and handling needed for more regular dosing of conventional dosage forms), caregiver or veterinarian convenience, and cost-effectiveness are some of the primary drivers for the development of a controlled and/or prolonged-release system in veterinary medicine.

Contrary to the delivery of a medicine in drinking water or food, controlled-release systems are not only easier to use than repeat-injection dosing, but also allow for the measurement of the drug's dosage. When compared to dosage via oral or injectable routes, topical administration for local or systemic effects frequently offers additional advantages such as reduced handling during administration. Thus, emergence of the controlled release technology is set to provide traction to the overall growth in the farm animal drugs market during the forecast period.

Get in Touch With Our Team For 20% Flat Discount:
https://www.futuremarketinsights.com/ask-question/rep-gb-2402

Category-wise Insights

Which is the Highly Preferred Product in the Farm Animal Drugs Industry?

"High Prevalence of Zoonotic Diseases to Drive Sales of Anti-infective Medications" By product, the anti-infective segment held a share of around 36.9% in the global farm animal drugs market in 2021. The segment is expected to hold the largest market share in the next decade owing to rising concerns regarding animal health, surging prevalence of zoonotic diseases, as well as transmission of these diseases to humans from animals.
Which Animals Are Set to Be the Dominant Users of Drugs?

"Antibiotics for Livestock to Gain Impetus with High Demand for Meat Products"

By animal, the livestock animals segment held the highest farm animal drugs market share of about 92.4% in 2021. With increasing reliance on animal and dairy products globally, there is an urgent need to prevent contamination of meat products, which would thus propel the livestock animals segment in the market. Disease prevention and control, as well as development of novel formulations for producing safe and quality foods are further expected to foster this segment.

Which is the Most Preferred Route of Administration of Drugs for Farm Animals?

"Large Animal Antibiotics to Be Provided through the Oral Route of Administration"

The oral route of administration segment held the highest market share of about 41.3% in 2021. In cattle, poultry, and pigs, the oral mode of administration is most frequently employed. Premixes, drinking water additives, tablets, capsules, drenches, licks, boluses, and pastes are some of the common examples of oral formulations. The segment is expected to hold a high market share over the forecast period owing to their ease of administration.

Which is the Leading Distribution Channel in the Farm Animal Drugs Industry?

"Antibiotics for Farm Animals to Be Made Available in Veterinary Hospitals"

Veterinary hospitals held a revenue share of about 45.6% in 2021 in the global farm animal drugs market. With the presence of skilled professionals, greater awareness about the health & management of livestock animals, and favorable government incentives, veterinary hospitals hold a dominant market share based on distribution channels in the global farm animal drugs market.

Competitive Landscape

Key players present in the global farm animal drugs market are focusing on expanding their product portfolios by engaging in acquisitions and mergers with local companies. A few other key players are investing huge sums in research and development activities to come up with novel formulations for maintaining the overall health of farm animals, as well as for increasing the quality of dairy products and meats while processing.

Some of the recent industry developments in the global market are:

In September 2022, the Indian Council of Agricultural Research (ICAR) announced that it is planning to commercially launch its indigenously-developed vaccine against the Lumpy Skin Disease (LSD) virus. The virus has killed nearly 50,000 heads of cattle across India since April.
In September 2022, Chhattisgarh government is planning to introduce Mukhyamantri Govansh Mobile Chikitsa Yojana, which would include a couple of veterinary units and veterinarians will be provided in every district. It would help in providing quality medical facilities to cattle in inaccessible & remote areas as part of the government's measures towards the protection & welfare of livestock.
Scope of the Farm Animal Drugs Market Report

Estimated Market Size (2022)

US$ 17.2 Bn

Projected Market Valuation (2032)

US$ 29.4 Bn

Value-based CAGR (2022-2032)

5.5%

Forecast Period

2012-2021

Historical Data Available for

2022-2032

Market Analysis

Value (US$ Bn)

Key Regions Covered

North America, Latin America, Europe, South Asia, East Asia, Oceania, and Middle East & Africa

Key Countries Covered

U.S., Canada, Brazil, Mexico, Argentina, U.K., Germany, Italy, Russia, Spain, France, BENELUX, India, Thailand, Indonesia, Malaysia, Japan, China, South Korea, Australia, New Zealand, Turkey, GCC Countries, North Africa, and South Africa

Key Market Segments Covered

Product, Route of Administration, Animal, Distribution Channel, and Region

Request Customization:
https://www.futuremarketinsights.com/customization-available/rep-gb-2402

Key Companies Profiled

Bayer AG
Boehringer Ingelheim GmbH
Zoetis, Inc.
Ceva Santé Animale
Dechra Pharmaceuticals PLC
Elanco Animal Health (Sub. Eli Lilly)
Merck Animal Health
Virbac SA
Vetoquinol SA
Intas Animal Health
Alembic Animal Health
Sequent Scientific
Hester Biosciences
Ashish Life Sciences
Ouro Fino Saude Animal (Ourofino)
Zydus Animal Health (Sub. Cadila Healthcare Ltd)
Phibro Animal Health Corporation
Nippon Zenyaku Kogyo Co., Ltd
Norbrook
Kyoritsu Seiyaku Corporation

Key Segments Covered in Farm Animal Drugs Market Analysis

By Product:

Anti-Infective
Parasiticides
Endo-parasiticides
Ecto-parasiticides
Endectocides
Anti-Inflammatory
Anesthetics
Analgesics
Hormones & Related Product
Others

By Animal:

Livestock Animals

Ruminants

Swine

Poultry

Equine

By Route of Administration:

Oral

Parenteral

Topical

Others

By Distribution Channel:

Veterinary Hospitals

Veterinary Clinics

Pharmacies and Drug Stores

Others

By Region:

North America

Latin America

Europe

South Asia

East Asia

Oceania

Middle East and Africa (MEA)

Contact:
Future Market Insights, Inc.   
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA   
T: +1-845-579-5705   
Enquiries: sales@futuremarketinsights.com    
LinkedIn| Twitter| Blogs

ABOUT FUTURE MARKET INSIGHTS, INC.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights. Sign Up for a 7 day free trial!

This release was published on openPR.